Novo CEO pressed by Senate to chop prices of weight problems, diabetes medicines CEO Lars Fruergaard Jørgensen told lawmakers the company would take into account new talks with insurers with regard to the list selling prices of Wegovy and copyright when they pledge to help keep the medicines on their https://gunnerqhxnd.ssnblog.com/30034522/not-known-facts-about-healthcare-news